Introduction
Placebos and placebo effects have held an ambivalent place in health care for at least 2 centuries. On the one hand, placebos are traditionally used as controls in clinical trials to correct for biases. Among other factors, these include regression to the mean, the natural course of the disorder, and effective co-interventions. In this context, the placebo effect is viewed as an effect to be factored out in order to isolate and accurately measure the specific effects of the treatment. On the other hand, there is mounting scientific evidence that placebo responses represent complex psychoneurobiological events involving the contribution of distinct central nervous system, as well as peripheral physiological mechanisms that influence pain perception, clinical symptoms, and substantially modulate the response to active analgesics.
In this review, we bring together 3 perspectives of placebo research, including psychological mechanisms, neurobiological pathways, and molecular substrates of placebo analgesia and their contribution to active pain medications. The emphasis is particularly on recent studies illuminating mechanisms underlying individual differences in placebo responsiveness.
Psychological aspects of placebo analgesia
From a psychological point of view, a series of recent studies supported the nature of the placebo effect as a learning phenomenon wherein a human being learns to produce a benefit via verbally induced expectations, cued and contextual conditioning, or social learning [9, 11] . Placebo analgesic effects can be elicited by verbal instructions that anticipate a benefit, thus creating expectations of analgesia and recalling previously acquired experiences of pain relief. These verbally induced expectations can be reinforced through manipulations in which a placebo treatment is paired with reduced pain intensities so that subjects come to experience analgesia and thereby enhance their expectations of future pain relief [8, 11, 28] . This procedure typically evokes much stronger and more stable placebo analgesic effects compared to verbally induced effects [8, 16] . Interestingly, recent evidence suggests that these effects can be triggered by contextual cues that are not consciously perceived, suggesting that placebo analgesic responses can operate outside of conscious awareness [15] . It is also noteworthy that conditioning can be induced by repetitive exposure to pharmacological treatments and produces drug-like effects when the active drug is replaced by a placebo. These effects, termed pharmacological conditioning, are quite robust in the field of pain and other conditions. Intriguingly, placebos given after preexposure to pharmacological treatments mirror the action of the pharmacological agent such as analgesics, for example, morphine and ketorolac Placebo analgesic effects can also occur without formal conditioning and direct prior experience because crucial information necessary to build up expectations of analgesia can be acquired through social learning. Colloca and Benedetti showed that substantial placebo analgesic responses were present after observing a benefit in another person undergoing an analgesic treatment [9] . Remarkably, the placebo analgesic effects following the observation of a benefit in another person were similar in magnitude to those induced by directly experiencing the benefit through a conditioning procedure and were positively correlated with the individual empathy traits of the observer. These observations emphasize that contextual cues and the entire atmosphere surrounding the participant or patient contribute to induce expectations of clinical benefit and recall memories of pain relief, and thereby substantially modulate the individual placebo analgesic response.
Neurochemistry of placebo analgesia
The above-described mechanisms are associated with specific central nervous system and peripheral physiological responses. Beginning with experiments in the 1960s, evidence from indirect pharmacological approaches and molecular imaging studies with positron emission tomography (PET) indicated that placebo analgesia is mediated by the release of endogenous neuromodulators, including opioids, cholecystokinin, cannabinoids, and dopamine. Levine et al. [18] first demonstrated that placebo analgesia can
